Sonova (OTCMKTS:SONVY) Stock Price Up 8.9% – Should You Buy?

Sonova Holding (OTCMKTS:SONVY) shares rose 8.9% on Tuesday . The company traded as high as $49.68 and last traded at $49.43. Approximately 820 shares traded hands during trading, a decline of 98% from the average daily volume of 41,011 shares. The stock had previously closed at $45.39.

Analyst Upgrades and Downgrades

SONVY has been the subject of a number of recent research reports. Citigroup reissued a “sell” rating on shares of Sonova in a research note on Wednesday, May 13th. Jefferies Financial Group cut Sonova from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, March 18th. Zacks Research upgraded Sonova from a “strong sell” rating to a “hold” rating in a research report on Monday, February 9th. Finally, BNP Paribas Exane upgraded Sonova from a “strong sell” rating to a “strong-buy” rating in a research report on Tuesday, March 10th. Two equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Sonova presently has a consensus rating of “Hold”.

Sonova Price Performance

The firm has a fifty day simple moving average of $46.04 and a 200 day simple moving average of $49.94. The company has a quick ratio of 0.91, a current ratio of 1.24 and a debt-to-equity ratio of 0.51.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.